Microbix specializes in developing proprietary biological technologies, which has lead to the development of a pipeline of products in three areas: biotherapeutics, vaccines and non-therapeutic biologics. The Company selects products for development based on potential near term market opportunity that will provide above average returns in a high margin business. Products in Microbix’ pipeline generally have limited regulatory barriers or no regulatory requirement at all before reaching the market.